Amos Bar-Shalev
Director · Protalix BioTherapeutics, Inc.
IndividualSelling only
- 2025
- Sep 4, 2026
- 3
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Amos Bar-Shalev. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Aharon Schwartz - $206K in PLX purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Amos Bar-Shalev?
Amos Bar-Shalev is a corporate insider, tracked as Director of Protalix BioTherapeutics, Inc. (PLX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Amos Bar-Shalev submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Amos Bar-Shalev been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($314) across all tracked filings.
